nitroxoline has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bertagnolo, V; Bologna, G; Brugnoli, F; Cama, A; Carletti, E; De Lellis, L; Di Bella, MC; Florio, R; Lanuti, P; Marchisio, M; Ronci, M; Scotti, L; Veschi, S | 1 |
| Brocco, D; Cama, A; Carradori, S; De Lellis, L; Florio, R; Guglielmi, P; Secci, D; Sobolev, AP; Spano, M; Veschi, S | 1 |
| Cama, A; De Lellis, L; De Tursi, M; di Sebastiano, P; Florio, R; Lanuti, P; Marchisio, M; Massucci, A; Natoli, C; Tinari, N; Veschi, S | 1 |
3 other study(ies) available for nitroxoline and Cancer of Pancreas
| Article | Year |
|---|---|
Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Damage; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Nitroquinolines; Pancreatic Neoplasms; Proteomics | 2020 |
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents.
Topics: Antineoplastic Agents; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Cell Proliferation; Humans; Nitroquinolines; Pancreatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2020 |
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Erlotinib Hydrochloride; Humans; Nelfinavir; Nitroquinolines; Pancreatic Neoplasms | 2018 |